Enhancing safety and compliance in acute behavioural disturbance management: Pilot of proposed update to zuclopenthixol acetate guidelines in a regional PICU
Published online on June 23, 2026
Abstract
Australasian Psychiatry, Ahead of Print.
ObjectivesZuclopenthixol acetate (ZA) is commonly used in psychiatric intensive care units (PICUs) to manage acute behavioural disturbance (ABD). Despite its clinical utility, monitoring practices remain inconsistent, creating issues such as oversedation ...
ObjectivesZuclopenthixol acetate (ZA) is commonly used in psychiatric intensive care units (PICUs) to manage acute behavioural disturbance (ABD). Despite its clinical utility, monitoring practices remain inconsistent, creating issues such as oversedation ...